Škrott Zdeněk Ph.D.
Journals
        Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase.        
                  Oncogene.                
                  2019,
                
                              38(40),
                  
                              6711-6722,
                          
                  ISSN: 0950-9232,
                
                
                              PMID: 31391554,                          
                
                          
        
      
    
        Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram.        
                  The Prostate.                
                  2018,
                
                              79(4),
                  
                              352-362,
                          
                  ISSN: 0270-4137,
                
                
                              PMID: 30499118,                          
                
                          
        
      
    Open positions
| Project: | Cellular stress in health and disease | 
|---|---|
| Supervisors: | Mistrík Martin Ph.D., Moudrý Pavel Ph.D., Škrott Zdeněk Ph.D. | 
| Available: | 3 | 
| Intended for: | Doctoral training | 
 
        